Oxford BioDynamics Future Growth
Future criteria checks 2/6
Oxford BioDynamics's earnings are forecast to decline at 4.5% per annum while its annual revenue is expected to grow at 85.3% per year. EPS is expected to grow by 32.1% per annum.
Key information
-4.5%
Earnings growth rate
32.1%
EPS growth rate
| Life Sciences earnings growth | 19.8% |
| Revenue growth rate | 85.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Here's Why We're Watching Oxford BioDynamics' (LON:OBD) Cash Burn Situation
Jan 18
Here's Why We're A Bit Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Situation
Oct 08Is Oxford BioDynamics (LON:OBD) In A Good Position To Invest In Growth?
Sep 21Oxford BioDynamics (LON:OBD) Is In A Good Position To Deliver On Growth Plans
May 24We're Not Very Worried About Oxford BioDynamics' (LON:OBD) Cash Burn Rate
Dec 07Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2025 | 2 | -12 | N/A | -10 | 1 |
| 9/30/2024 | 1 | -11 | N/A | -10 | 1 |
| 3/31/2024 | 1 | -11 | -7 | -7 | N/A |
| 12/31/2023 | 1 | -11 | -8 | -7 | N/A |
| 9/30/2023 | 1 | -11 | -9 | -8 | N/A |
| 6/30/2023 | 0 | -10 | -9 | -8 | N/A |
| 3/31/2023 | 0 | -8 | -9 | -8 | N/A |
| 12/31/2022 | 0 | -7 | -7 | -7 | N/A |
| 9/30/2022 | 0 | -7 | -6 | -5 | N/A |
| 6/30/2022 | 0 | -7 | -7 | -5 | N/A |
| 3/31/2022 | 0 | -6 | -9 | -5 | N/A |
| 12/31/2021 | 0 | -7 | -9 | -6 | N/A |
| 9/30/2021 | 0 | -7 | -9 | -6 | N/A |
| 6/30/2021 | 0 | -6 | -7 | -5 | N/A |
| 3/31/2021 | 1 | -5 | -6 | -5 | N/A |
| 12/31/2020 | 0 | -5 | -5 | -4 | N/A |
| 9/30/2020 | 0 | -4 | -4 | -3 | N/A |
| 6/30/2020 | 0 | -4 | -4 | -3 | N/A |
| 3/31/2020 | 1 | -4 | -3 | -3 | N/A |
| 12/31/2019 | 1 | -3 | -3 | -3 | N/A |
| 9/30/2019 | 1 | -3 | -3 | -2 | N/A |
| 6/30/2019 | 1 | -2 | -3 | -2 | N/A |
| 3/31/2019 | 1 | -2 | -3 | -2 | N/A |
| 12/31/2018 | 1 | -2 | -3 | -2 | N/A |
| 9/30/2018 | 1 | -2 | -3 | -2 | N/A |
| 6/30/2018 | 1 | -2 | -2 | -2 | N/A |
| 3/31/2018 | 1 | -2 | -2 | -1 | N/A |
| 12/31/2017 | 1 | -3 | N/A | -1 | N/A |
| 9/30/2017 | 1 | -4 | N/A | -2 | N/A |
| 6/30/2017 | 1 | -4 | N/A | -1 | N/A |
| 3/31/2017 | 1 | -4 | N/A | -1 | N/A |
| 12/31/2016 | 1 | -3 | N/A | -1 | N/A |
| 9/30/2016 | 1 | -2 | N/A | -1 | N/A |
| 6/30/2016 | 1 | -2 | N/A | -2 | N/A |
| 3/31/2016 | 1 | -1 | N/A | -2 | N/A |
| 12/31/2015 | 1 | -1 | N/A | -2 | N/A |
| 9/30/2015 | 1 | -1 | N/A | -1 | N/A |
| 9/30/2014 | 1 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OBD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OBD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OBD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OBD's revenue (85.3% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: OBD's revenue (85.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OBD's Return on Equity is forecast to be high in 3 years time